Relieves symptoms associated with acute and recurrent diabetic gastric stasis. ANDA 71402, held by ANI Pharmaceuticals. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 71402 (Metoclopramide Hydrochloride), held by ANI Pharmaceuticals, was first approved by FDA on Jun 25, 1993, with 8 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE The use of Metoclopramide Oral Solution is recommended for adults only. Therapy should not exceed 12 weeks in duration. Symptomatic Gastroesophageal Reflux Metoclopramide Oral Solution is indicated as short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy. The principal effect of metoclopramide is on symptoms of post-prandial and daytime heartburn with less observed effect on nocturnal symptoms.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 25, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 5MG BASE/5ML · solution;oral | Metoclopramide Hydrochloride | Rx |
| Jul 28, 2015 | Supplement 12Labeling · Standard review | Approved | None posted |
| Dec 16, 2014 | Supplement 5Labeling | Approved | None posted |
| Jul 31, 2012 | Supplement 11Labeling · Standard review | Approved | None posted |
| Feb 28, 2011 | Supplement 10Labeling | Approved | None posted |
| Mar 31, 2010 | Supplement 9Labeling | Approved | None posted |
| Sep 16, 2009 | Supplement 8Labeling | Approved | |
| Jun 30, 2009 | Supplement 7Labeling | Approved | |
| Oct 28, 2008 | Supplement 6Labeling | Approved | None posted |
| Jun 25, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters